Patents Assigned to PELVIPHARM
  • Method for Restoring an Ejaculatory Failure
    Publication number: 20110022131
    Abstract: The present invention relates to a method for eliciting ejaculation in a male individual, comprising delivering one or more stimulation pulses to lumbar spinothalamic (LSt) cells via a light stimulus, wherein said LSt cells express a light-activated cation channel protein.
    Type: Application
    Filed: April 1, 2009
    Publication date: January 27, 2011
    Applicant: PELVIPHARM
    Inventor: Francois Giuliano
  • Use of a Combination of Udenafil and Alfuzosin or Oxybutynin for the Treatment of Overactive Bladder
    Publication number: 20110021542
    Abstract: The invention relates to a specific combination of two active agents: udenafil and one of alfuzosin and oxybutynin and its use for the treatment of overactive bladder.
    Type: Application
    Filed: April 2, 2009
    Publication date: January 27, 2011
    Applicant: PELVIPHARM
    Inventors: Francois Giuliano, Delphine Behr-Roussel
  • METHOD FOR RESTORING AN EJACULATORY FAILURE
    Publication number: 20110009937
    Abstract: A method for eliciting ejaculation in a male individual, comprising delivering one or more stimulation pulses to lumbar spinothalamic (LSt) cells.
    Type: Application
    Filed: July 10, 2008
    Publication date: January 13, 2011
    Applicant: PELVIPHARM
    Inventors: Jacques Bernabe, Aren Borgdorff, Francois Giuliano
  • METHOD FOR RESTORING AN EJACULATORY FAILURE
    Publication number: 20090018620
    Abstract: The present invention relates to a method for eliciting ejaculation in a male individual, comprising delivering one or more stimulation pulses to lumbar spinothalamic (LSt) cells.
    Type: Application
    Filed: October 9, 2007
    Publication date: January 15, 2009
    Applicant: PELVIPHARM
    Inventors: Jacques Bernabe, Aren Borgdorff, Francois Giuliano